{{Drugbox
| IUPAC_name = N-(1-amino-3-phenyl-1-oxopropan-2-yl)-1-[(4-fluorophenyl)methyl]-1H-indazole-3-carboxamide
| image = APP-FUBINACA.png

<!--Clinical data-->
| tradename =  
| pregnancy_AU = 
| pregnancy_US = 
| pregnancy_category =  
| legal_AU = 
| legal_CA = Schedule II
| legal_UK = 
| legal_US = 
| legal_status = 
| routes_of_administration =  

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =  

<!--Identifiers-->
| CAS_number_Ref = 
| CAS_number = 1185282-03-4
| ATC_prefix =  
| ATC_suffix =  
| PubChem = 58124515
| ChemSpiderID      = 
| smiles            = O=C(N[C@H](C(N)=O)CC1=CC=CC=C1)C2=NN(CC3=CC=C(F)C=C3)C4=C2C=CC=C4
| StdInChI          = 1S/C24H21FN4O2/c25-18-12-10-17(11-13-18)15-29-21-9-5-4-8-19(21)22(28-29)24(31)27-20(23(26)30)14-16-6-2-1-3-7-16/h1-13,20H,14-15H2,(H2,26,30)(H,27,31)/t20-/m0/s1
| StdInChIKey       = TZXBEYFALIFOAG-FQEVSTJZSA-N

<!--Chemical data-->
| C=24 | H=21 | F=1 | N=4 | O=2 
| molecular_weight = 416.5 g/mol
}}

'''APP-FUBINACA''' is an [[indazole]]-based [[synthetic cannabinoid]] that has been sold online as a [[designer drug]].<ref>{{cite web | url=https://www.caymanchem.com/app/template/Product.vm/catalog/17200 | title=APP-FUBINACA | publisher=Cayman Chemical | accessdate=15 July 2015}}</ref> Pharmacological testing showed APP-FUBINACA to have only moderate affinity for the [[CB1 receptor|CB<sub>1</sub> receptor]], with a Ki of 708 nM, while its EC<sub>50</sub> was not tested.<ref>[http://patentscope.wipo.int/search/en/detail.jsf?docId=WO2009106982 Buchler IP et al, INDAZOLE DERIVATIVES. WO 2009/106982]</ref> It contains a [[phenylalanine]] amino acid residue in its structure.

==Legality==
Sweden's public health agency suggested to classify APP-FUBINACA as hazardous substance on March 24, 2015.<ref>{{cite web | url=http://www.folkhalsomyndigheten.se/nyheter-och-press/nyhetsarkiv/2015/mars/fler-amnen-foreslas-bli-klassade-som-narkotika-eller-halsofarlig-vara/ | title=Fler ämnen föreslås bli klassade som narkotika eller hälsofarlig vara | publisher=Folkhälsomyndigheten | accessdate=16 July 2015}}</ref>

==See also==
{{div col|colwidth=30em}}
* [[5F-AB-PINACA]]
* [[5F-ADB]]
* [[5F-AMB]]
* [[5F-APINACA]]
* [[AB-FUBINACA]]
* [[AB-CHFUPYCA]]
* [[AB-CHMINACA]]
* [[AB-PINACA]]
* [[ADB-CHMINACA]]
* [[ADB-FUBINACA]]
* [[ADB-PINACA]]
* [[ADBICA]]
* [[APICA]]
* [[APINACA]]
* [[MDMB-CHMICA]]
* [[MDMB-FUBINACA]]
* [[PX-1]]
* [[PX-2]]
* [[PX-3]]
{{Div col end}}

==References==
{{Reflist}}

{{Cannabinoids}}
{{Cannabinoidergics}}

[[Category:Indazoles]]
[[Category:Cannabinoids]]
[[Category:Designer drugs]]
[[Category:Indazolecarboxamides]]
[[Category:Fluoroarenes]]

{{cannabinoid-stub}}